awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47732542-41F1D04D-A221-4D21-9082-58D337CC5F04
Q47732542-41F1D04D-A221-4D21-9082-58D337CC5F04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47732542-41F1D04D-A221-4D21-9082-58D337CC5F04
Immunoengineering with biomaterials for enhanced cancer immunotherapy.
P2860
Q47732542-41F1D04D-A221-4D21-9082-58D337CC5F04
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47732542-41F1D04D-A221-4D21-9082-58D337CC5F04
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ff5df35c0cd1cd76748c5cf7e784648ffe31b54
P2860
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.